Korea reported 269 new omicron variant cases on Friday, marking the highest daily level and bringing the total to 894.Due to the rapid spread of the new variant and the undiminishing number of critically ill Covid-19 patients, the government extended the current social distancing rules for another t
The government said Thursday that it is preparing new nationwide social distancing measures, considering the newly dominant Omicron variant.“Most countries are struggling to cope with the resurge of new virus cases due to the Omicron variant,” Vice Minister of Health and Welfare Ryu Keun-hyuck said
Daewoong Pharmaceutical said Thursday that its Fexuclue has won regulatory approval as a new drug for gastroesophageal reflux disease (GERD).The company said the Ministry of Food and Drug Safety authorized 40 milligrams of Fexuclue for erosive GERD. It plans to apply for setting the share of insuran
AbClon has received regulatory approval to conduct phase 1 and 2 clinical trials of AT101, a CAR-T therapy with new antibodies, for blood cancer patients.AT101 is a CAR-T immuno-oncology that targets the CD19 protein, and its application area is completely different from the existing global blockbus
Moderna, a biotech company developing messenger RNA (mRNA) therapeutics, has revealed a revised agreement to supply 20 million doses of its Covid-19 vaccines and updated booster candidates to Korea in 2022.Under the new accord, the company will provide 15 million doses for delivery in the third quar
Health officials said they would shorten isolation time for people infected with the Omicron variant and those who had close contact with them from 14 to 10 days.Officials said Tuesday that they planned to curtail the isolation period for the Omicron-infected people as the variant did not show diffe
Until the mid-20th century, there had been no concept of surgery in fractures.People called fracture “fracture disease” because many complications occurred in treating fractures, such as pressure sores, infections, and even pneumonia. In the 1950s, a group of Swiss orthopedists formed a study group
EOFlow, a biotech specializing in drug delivery platforms, said its U.S. branch EOFlow Inc. and Zihipp, a spin-out firm of Imperial College London, have agreed to establish a joint venture in the U.S. for weight loss.The new joint venture named SanPlena will focus on developing wearable injectable d
Kolon TissueGene said it has resumed administering Invossa (TG-C), cell-mediated gene therapy for osteoarthritis, in phase 3 clinical trials for knee osteoarthritis in the United States.The medication began in Source Healthcare in Santa Monica, Calif. The company plans to complete the trials of Invo
The government may likely announce prolonging social distancing measures on Friday, considering the possibility of a wider spread of the Omicron variant during the year-end and New Year holidays.Faced with the resurge of Covid-19 cases, Korea suspended the “living with Covid-19” system about 10 days
LegoChem Biosciences has signed a co-development and technology transfer agreement with the U.K. Iksuda Therapeutics for LCB14, an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2) undergoing studies in China.Under the accord, Iksuda gained exclusive rights for
Lunit said Monday that its latest AI solution has obtained the Medical Device Single Audit Program (MDSAP) certificate, issued by five major countries after conducting one regulatory audit of a medical device.The company will be partially or fully exempted from a duplicate regulatory procedure from
HLB said it has verified the safety and protection of the Covid-19 vaccine, Nanocovax, developed by Vietnam-based pharmaceutical company, Nanogen. The Vietnamese Ministry of Health said that the protective effect of Nanocovax exceeded 50 percent of the minimum standard suggested by the World Health
MedPacto, University of California San Francisco (UCSF), and MSD have teamed up to conduct investigator-initiated clinical trials to develop therapies for colon cancer.Professor Chloe Atreya at the UCSF Helen Diller Family Comprehensive Cancer Center will lead the study to check the efficacy of Vact
A research team at Seoul National University Hospital (SNUH) has presented an accurate report of deep spinal infection's frequency and risk factors, one of the fatal side effects occurring after epidural injection.The researchers, led by Professor Moon Jee-youn of the Department of Anesthesiolo
A research team at Pohang University of Science and Technology (POSTECH) has developed a diagnostic technology to detect the Covid-19 variant Omicron in just 20 minutes.The research team, led by Professor Lee Jeong-wook of the Department of Chemical Engineering, said the technology could also catch
Samsung Bioepis said Thursday that SB3, a biosimilar of Herceptin (ingredient: trastuzumab), showed similar long-term survival results to its original drug after a median follow-up of 68 months from the phase 3 study.The five-year results are the longest monitored data as of December 2021 for a tras
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical Review correspondent - The 2021 Radiological Society of North America (RSNA 2021) successfully finished its five day-run at the McCormick Place Convention Center last Thursday, with global companies, including Korean firms, demonstrating the latest
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical Review correspondent - Samsung Electronics has laid out its latest ultrasound and digital radiography products for the first time in the U.S. with other imaging technologies at the Radiological Society of North America (RSNA) 2021.With an array of d
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical Review correspondent - Lunit, a medical AI solution developer, plans to focus more on the U.S. market next year, starting with its deep learning-based software that recently received clearance from the U.S. Food and Drug Administration.The company h